●島根県内の発生状況(血清型、毒素型別)
血清型 | 毒素型 | 発生年 | 合計 |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
O15 | VT1 | | | 1 | | | | |
| | | | | 1 |
O16:H5 | VT2 | | | | | | | |
| | | 1(1) | | 1(1) |
O26 | VT1 | | 1 | 1(1) | | | | 7(4) | |
2(1) | | | 1 | 12(6) |
O26:H11 | VT1 | 6(5) | 4(2) | 13(5) | | 3 | 6(3) | |
| | | | | 32(15) |
VT1VT2 | 56(25) | | | | | | | | |
| | | 56(25) |
O26:HUT | VT1 | | | 1(1) | | | | |
| | | | | 1(1) |
O103:H2 | VT1 | | | | | | | |
| | | 4(3) | | 4(3) |
O103:HUT | VT1 | 1(1) | | | | | | |
| | | | | 1(1) |
VT1VT2 | 2(1) | | | | | | | | |
| | | 2(1) |
O111:H- | VT1 | | | | | | | 2 |
| | | | | 2 |
VT1VT2 | | | | | | | | | |
| | 1 | 1 |
O111:H8 | VT1VT2 | | | | | | | |
| | 2(1) | | | 2(1) |
O111:H21 | VT1 | | | | | | | 1 |
| | | | | 1 |
VT2 | 1 | | | | | | | | |
| | | 1 |
O111:HUT | VT1 | | | 20(12) | | | | |
| | | | | 20(12) |
O115 | VT2 | | | | 1 | | | |
| | | | | 1 |
O115:H10 | VT1 | | | | | | | |
| | | 1(1) | | 1(1) |
O121 | VT2 | | | | | | | |
| 1 | | | | 1 |
O121:H19 | VT2 | 1 | 1 | | 3(2) | | | | |
1 | 1 | | | 7(2) |
O145:H28 | VT2 | | | | | | | |
| 1 | | | | 1 |
O145:H41 | VT2 | | 2(1) | | | | | |
| | | | | 2(1) |
O145:HNM | VT2 | | 1 | | | | | |
| | | | | 1 |
O157 | VT1 | 1 | | | | | | |
| | | | | 1 |
VT2 | | | 2 | 4(1) | | 1 | | 1(1) | | |
| | 8(2) |
VT1VT2 | | 1 | | | | | | 3(2) | |
| | | 4(2) |
VT(型不明) | | | | | | | | 1 | 1 |
| | | 2 |
O157:H- | VT1VT2 | | | | | | | |
| | | | 4(2) | 4(2) |
O157:H7 | VT2 | 4(1) | 14(5) | 5(3) | 2(1) | 74(37) | 4(2) | 1 |
12(6) | 1 | 8(2) | 3(1) | 9(4) | 137(62) |
VT1VT2 | 1 | 4(1) | 2 | 5(1) | 5 | 1 | 2(1) | 1 | 1 | 1(1) |
3(1) | 5(1) | 31(6) |
O157:H21 | VT1VT2 | 1(1) | | | | | | |
| | | | | 1(1) |
O157:HUT | VT1 | 1 | | | | | | |
| | | | | 1 |
VT1VT2 | 1 | 2(1) | | | | | | | |
| | | 3(1) |
O169:H9 | VT1 | | | | | | | |
| | | 1(1) | | 1(1) |
計 | 76(34) | 31(10) | 45(22) | 16(5) | 83(37) | 12(5) | 13(5) | 18(9) | 8(1) |
12(4) | 13(8) | 20(7) | 347(147) |
2023年12週 現在。 ( )内は、無症状病原体保有者の再掲です。
HUT:H型別 UnTyped HNM: H型別 NoMove
2015年 計83(37)については、別途、HUS発症による届出受理患者(血清:O157LPS抗体陽性)1名を含みます。
2021年のO116:H9は、PCRにより型別されたものです。